Article Details

ImmunoGenesis Announces Publication of Phase 1 Data on its Hypoxia-Reversal Agent ...

Retrieved on: 2021-06-16 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

ImmunoGenesis Announces Publication of Phase 1 Data on its Hypoxia-Reversal Agent .... View article details on hiswai:

Excerpt

ImmunoGenesis is a clinical-stage biotechnology company developing therapeutics to catalyze effective immune responses in immunologically cold ...

Article found on: www.inforney.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up